ClinicalTrials.Veeva

Menu

The Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF

H

Huazhong University of Science and Technology

Status

Enrolling

Conditions

Repeated Implantation Failure

Treatments

Device: sham acupuncture and IVF
Device: acupuncture and IVF

Study type

Interventional

Funder types

Other

Identifiers

NCT04533295
2019CR110

Details and patient eligibility

About

The randomized, placebo-controlled multicenter trial is conducted in five centers in China. After screening and obtaining the signed informed consent , the participants are randomly divided into two groups: acupuncture +IVF group and sham acupuncture +IVF group.

Enrollment

514 estimated patients

Sex

Female

Ages

25 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Married women aged 25-40;
  2. Repeated implantation failure for unknown reasons (after 3 or more consecutive cycles of embryo transfer, or cumulative transfer of ≥6 high-quality cleavage embryos or 4 high-quality blastocysts without clinical pregnancy);
  3. Transplantable Day 3 high-quality frozen embryos or frozen blastocysts (≥3BB);
  4. Estrogen and progesterone replacement therapy (HRT), endometrial thickness ≥7mm on the day of endometrial transformation.

Exclusion criteria

Patients who met any of the following conditions were not included.

  1. Those who prepare for PGD;
  2. Recipients of egg donors;
  3. Chromosomal abnormalities in both or one of the couples (excluding chromosome polymorphism);
  4. patients with implantation failure due to known embryonic factors;
  5. Uterine lesions that may affect implantation (including uterine malformation, uterine tuberculosis, history of intrauterine adhesions, submucosal fibroids, adenomyosis, >4cm intramural fibroids)
  6. Repeated spontaneous abortion (2 or more fetal loss before 28 weeks of gestation);
  7. Patients with other endocrine diseases, such as thyroid disease, hyperprolactinemia, insulin resistance, diabetes, adrenal disease, etc., and poor control of hormone levels in the last 3 months;
  8. Clearly diagnosed autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, etc.;
  9. Hydrosalpinx untreated;
  10. BMI less than 18 and higher than 25kg/m2;
  11. People with previous history of needle sickness;
  12. Those who had previously participated in this study or had received acupuncture treatment in the past 3 months.
  13. Any situation that researchers consider inappropriate for participating in this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

514 participants in 2 patient groups

Acupuncture and IVF
Experimental group
Description:
Acupuncture and IVF
Treatment:
Device: acupuncture and IVF
Sham acupuncture and IVF
Sham Comparator group
Description:
Sham acupuncture and IVF
Treatment:
Device: sham acupuncture and IVF

Trial contacts and locations

1

Loading...

Central trial contact

Cuihong Zheng, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems